Your browser doesn't support javascript.
loading
Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantation.
Watanabe, Marika; Yakushijin, Kimikazu; Tanaka, Hidekazu; Chijiki, Ruri; Saeki, Miki; Hirakawa, Yuri; Takakura, Hidetomo; Usui, Yutaro; Ichikawa, Hiroya; Sakai, Rina; Matsumoto, Sakuya; Nagao, Shigeki; Mizutani, Yu; Kurata, Keiji; Kitao, Akihito; Miyata, Yoshiharu; Saito, Yasuyuki; Kawamoto, Shinichiro; Yamamoto, Katsuya; Ito, Mitsuhiro; Matsuoka, Hiroshi; Minami, Hironobu.
Afiliación
  • Watanabe M; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Yakushijin K; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Tanaka H; Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.
  • Chijiki R; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Saeki M; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Hirakawa Y; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Takakura H; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Usui Y; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Ichikawa H; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Sakai R; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Matsumoto S; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Nagao S; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Mizutani Y; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Kurata K; Jerome Lipper Multiple Myeloma Center Department of Medical Oncology Dana-Farber Cancer Institute Harvard Medical School Boston Massachusetts USA.
  • Kitao A; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Miyata Y; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Saito Y; BioResource Center Kobe University Hospital Kobe Japan.
  • Kawamoto S; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Yamamoto K; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Ito M; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Matsuoka H; Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan.
  • Minami H; Laboratory of Hematology Division of Medical Biophysics Kobe University Graduate School of Health Sciences Kobe Japan.
EJHaem ; 4(1): 192-198, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36819160
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: EJHaem Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: EJHaem Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos